FFCP PHASE1:Hg19::chr6:68597965..68597975,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C93 | |||
|description=CAGE_peak_at_chr6:68597965..68597975,- | |||
|id=chr6:68597965..68597975,- | |||
|ontology_enrichment_celltype=CL:0000763!3.36e-26!112;CL:0000049!3.36e-26!112;CL:0002032!1.96e-19!165;CL:0000837!1.96e-19!165;CL:0000037!1.47e-18!172;CL:0000566!1.47e-18!172;CL:0000988!2.00e-17!182;CL:0000134!9.75e-08!358;CL:0002320!1.53e-07!365;CL:0000219!7.48e-07!390;CL:0000054!8.52e-07!2;CL:0000137!8.52e-07!2;CL:0000092!8.52e-07!2 | |||
|ontology_enrichment_celltype_v019=CL:0000763;6.67e-11;100!CL:0000054;1.94e-09;2!CL:0000137;1.94e-09;2!CL:0000092;1.94e-09;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000763,5.64e-21,108;CL:0000049,5.64e-21,108;CL:0002032,7.73e-14,161;CL:0000837,7.73e-14,161;CL:0000037,3.15e-13,168;CL:0000988,1.64e-12,177;CL:0000054,2.02e-09,2;CL:0000137,2.02e-09,2;CL:0000092,2.02e-09,2 | |||
|ontology_enrichment_development_v019=CL:0000049;3.77e-10;108 | |||
|ontology_enrichment_disease=DOID:8692!4.86e-89!31;DOID:1240!1.74e-79!39;DOID:2531!7.94e-68!51;DOID:0060083!7.94e-68!51;DOID:1036!1.94e-67!8;DOID:0050686!8.26e-24!137;DOID:162!5.22e-13!235;DOID:14566!1.08e-12!239;DOID:0060085!2.46e-12!1;DOID:3165!2.46e-12!1;DOID:0060121!2.46e-12!1;DOID:2438!2.46e-12!1;DOID:4418!2.46e-12!1;DOID:200!8.52e-07!2;DOID:4305!8.52e-07!2 | |||
|ontology_enrichment_disease_v019=DOID:1036;1.36e-99;8!DOID:8692;3.86e-62;31!DOID:1240;3.06e-42;39!DOID:2531;1.28e-29;51!DOID:0060083;1.28e-29;51!DOID:0060085;1.57e-17;1!DOID:3165;1.57e-17;1!DOID:0060121;1.57e-17;1!DOID:2438;1.57e-17;1!DOID:4418;1.57e-17;1!DOID:200;1.94e-09;2!DOID:4305;1.94e-09;2 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,1.36e-99,8;DOID:8692,1.95e-63,31;DOID:1240,2.56e-50,39;DOID:2531,1.28e-45,51;DOID:0060083,1.28e-45,51;DOID:0060085,1.70e-17,1;DOID:3165,1.70e-17,1;DOID:0060121,1.70e-17,1;DOID:2438,1.70e-17,1;DOID:4418,1.70e-17,1;DOID:0050686,2.14e-16,137;DOID:200,2.02e-09,2;DOID:4305,2.02e-09,2;DOID:162,3.37e-09,235;DOID:14566,5.49e-09,239 | |||
|ontology_enrichment_uberon=UBERON:0002384!2.82e-07!375 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.399158742865633,0,0,3.24621940274555,0,0.912938716132769,0,0,0,0.321176150207399,0,0,0,5.8375745218607,4.69719826574073,4.83862510964535,0.390776190804081,0.278406173895242,0,0,0,0,0,0,0,0.111443384277478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.72678282034527,0,2.70714792740617,4.90156335794349,2.3495022176618,4.17458211993207,3.17873157960757,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.19228767021794,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.46277562248017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr6:68597965..68597975,- | |||
}} |
Revision as of 12:32, 22 January 2014
Short description: | p@chr6:68597965..68597975, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr6:68597965..68597975, - |
Coexpression cluster: | C93_chronic_acute_leukemia_acantholytic_medulloblastoma_testis_papillotubular |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
myeloid cell | 5.64e-21 | 108 |
common myeloid progenitor | 5.64e-21 | 108 |
hematopoietic oligopotent progenitor cell | 7.73e-14 | 161 |
hematopoietic multipotent progenitor cell | 7.73e-14 | 161 |
hematopoietic stem cell | 3.15e-13 | 168 |
hematopoietic cell | 1.64e-12 | 177 |
bone matrix secreting cell | 2.02e-09 | 2 |
osteocyte | 2.02e-09 | 2 |
osteoclast | 2.02e-09 | 2 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 1.36e-99 | 8 |
myeloid leukemia | 1.95e-63 | 31 |
leukemia | 2.56e-50 | 39 |
hematologic cancer | 1.28e-45 | 51 |
immune system cancer | 1.28e-45 | 51 |
organ system benign neoplasm | 1.70e-17 | 1 |
skin benign neoplasm | 1.70e-17 | 1 |
integumentary system benign neoplasm | 1.70e-17 | 1 |
dermis tumor | 1.70e-17 | 1 |
cutaneous fibrous histiocytoma | 1.70e-17 | 1 |
organ system cancer | 2.14e-16 | 137 |
giant cell tumor | 2.02e-09 | 2 |
bone giant cell tumor | 2.02e-09 | 2 |
cancer | 3.37e-09 | 235 |
disease of cellular proliferation | 5.49e-09 | 239 |